RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:54251

Aseptic abscess syndrome

high confidenceDisorder

Also known as: Aseptic abscesses syndrome · Aseptic systemic abscesses · Corticosteroid-sensitive aseptic abscess syndrome · Disseminated aseptic abscesses

Publications

75

49.5th percentile

Trials

1

Interventional, condition-specific

Researchers

468

Distinct authors in sample

Gene link

—

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A rare autoinflammatory disorder characterized by recurrent attacks of fever and sterile abscesses.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

aseptic abscesses syndrome · aseptic systemic abscesses · disseminated aseptic abscesses

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    75 matched papers (58 in last 10 years) Source

  3. Phenotype characterisedPresent

    17 HPO annotations (e.g. Fever; Elevated circulating C-reactive protein concentration; Weight loss) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialPresent

    1 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

17

Associated phenotypes · MONDO:0018900

  • Fever
  • Elevated circulating C-reactive protein concentration
  • Weight loss
  • Anemia
  • Abdominal pain

Showing 5 of 17 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

75

75 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

75 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

58 in the last 10 years · high confidence · 49.5th percentile (publications denominator)

Phrase hits: 75 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

468

Distinct author names in 75 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Aumaître O5 papers · 2014
    Papers in Europe PMC
  2. 02
    Piette JC5 papers · 2022

    Service de Médecine Interne, AP-HP Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France.

    Papers in Europe PMC
  3. 03
    Marzano AV4 papers · 2022

    Department of Pathophysiology and Transplantation, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Italy. angelovalerio.marzano@policlinico.mi.it

    Papers in Europe PMC
  4. 04
    André M3 papers · 2022

    Department of Internal Medicine, University Hospital Gabriel Montpied, Clermont-Ferrand, France.

    Papers in Europe PMC
  5. 05
    André MF3 papers · 2014

    Inserm, U931, GReD, Faculté de Médecine, Clermont-Ferrand, France. mandre@chu-clermontferrand.fr

    Papers in Europe PMC
  6. 06
    Grateau G3 papers · 2018

    Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, université Pierre-et-Marie-Curie (UPMC)-Paris 6, hôpital Trousseau, Assistance publique-Hôpitaux de Paris, 75012 Paris, France; Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France.

    Papers in Europe PMC
  7. 07
    Alaibac M2 papers · 2023

    Dermatology Unit, Department of Medicine, University of Padova, I-35128 Padova, Italy.

    Papers in Europe PMC
  8. 08
    Andre M2 papers · 2023

    Inserm U1071, M2iSH, USC-INRA 1382, Université Clermont Auvergne, Clermont-Ferrand, Auvergne-Rhône-Alpes, France.

    Papers in Europe PMC
  9. 09
    Aumaitre O2 papers · 2022

    Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.

    Papers in Europe PMC
  10. 10
    Cardoso MC2 papers · 2010
    Papers in Europe PMC

Clinical research

Is a treatment being tested?

1

interventional trials for this specific condition

1 interventional trial matched this specific condition name; none in our sample are currently recruiting.

Data as of 11 September 2026

1 interventional trial — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 80.1th percentile).

high confidence · 80.1th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

1 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 1 · after dedupe 1 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 1 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Uncertain / not reviewed (1)

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Aseptic abscess syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Aseptic abscess syndrome" OR "Aseptic abscesses syndrome" OR "Aseptic systemic abscesses" OR "Corticosteroid-sensitive aseptic abscess syndrome" OR "Disseminated aseptic abscesses"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Aseptic abscess syndrome" OR "Aseptic abscesses syndrome" OR "Aseptic systemic abscesses" OR "Corticosteroid-sensitive aseptic abscess syndrome" OR "Disseminated aseptic abscesses"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T00:55:49.703Z